Response to Comment on: Comparative outcomes of intralesional collagenase injection for Peyronie’s disease: acute vs. stable phase treatment
- 21 August 2025
- journal article
- editorial
- Published by Springer Nature in International Journal Of Impotence Research
- Vol. 37 (12) , 1015-1016
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Comment on: Comparative outcomes of intralesional collagenase injection for Peyronie’s disease: acute vs stable phase treatmentInternational Journal Of Impotence Research, 2025
- Comparative outcomes of intralesional collagenase injection for Peyronie’s disease: acute vs. stable phase treatmentInternational Journal Of Impotence Research, 2025
- Intralesional collagenase Clostridium histolyticum for acute phase Peyronie’s disease: a single-center, retrospective cohort studyTranslational Andrology and Urology, 2022
- Mental Disorders in Peyronie’s Disease: A Swedish Cohort Study of 3.5 Million MenJournal of Urology, 2021
- Safety and Efficacy of Collagenase Clostridium histolyticum in the Treatment of Acute Phase Peyronie's Disease: A Multi-institutional AnalysisUrology, 2020
- An Analysis of the Natural History of Peyronie’s DiseaseJournal of Urology, 2006
- A retrospective review of 307 men with Peyronie's disease.2002
- A Retrospective Review of 307 Men With Peyronie’s DiseaseJournal of Urology, 2002